GO:0003193 pulmonary valve formation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003193 pulmonary valve formation describes the developmental process that builds the initial pulmonary valve from unspecified parts, ending when the structural rudiment becomes recognizable.
• The process is a biological_process ontology term, not a molecular function or cellular component, and it is distinct from later valve remodeling and maturation.
• Key molecular players include NOTCH signaling, APOE, phospholipase C epsilon (PLCE1), and semilunar valvulogenesis regulators identified in mouse and human studies.
• Disruption of pulmonary valve formation contributes to congenital heart defects such as tetralogy of Fallot and semilunar valvulogenesis defects.
• Research models include mouse knockouts, surgical correction models, and transcatheter valve systems that inform both developmental biology and clinical translation.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in pulmonary valve formation.
Description
Pulmonary valve formation (GO:0003193) is the developmental process pertaining to the initial formation of the pulmonary valve from unspecified parts. According to the QuickGO definition, this process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. This term is a biological_process ontology entry, meaning it describes a developmental program rather than a single molecular activity or a static cellular component. Understanding this term is essential for researchers studying congenital heart disease, semilunar valve development, and the molecular signals that pattern the right ventricular outflow tract. The pulmonary valve is a semilunar valve that guards the outflow from the right ventricle into the pulmonary artery. Its formation is a critical step in cardiac morphogenesis, and defects in this process are associated with clinically significant congenital anomalies. Experimental work in mice has shown that disruption of specific signaling molecules, such as phospholipase C epsilon, leads to congenital semilunar valvulogenesis defects, directly linking molecular pathways to the formation of the pulmonary valve. In human clinical research, surgical strategies for tetralogy of Fallot have explored pulmonary valve formation from the right atrium, underscoring the translational importance of understanding how this valve develops and can be reconstructed. For biomedical researchers, GO:0003193 provides a precise annotation target for transcriptomic, proteomic, and functional genomic studies of valve development. It also serves as a framework for interpreting gene expression changes during cardiac differentiation and for designing CRISPR-based models that test the causal role of candidate genes in pulmonary valve formation.
pulmonary valve formation At A Glance
| GO ID | GO:0003193 |
|---|---|
| GO term | pulmonary valve formation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Initial formation of the pulmonary valve from unspecified parts, ending when the structural rudiment is recognizable |
| Definition source | QuickGO definition |
| Related processes | Semilunar valvulogenesis, cardiac outflow tract development, valve remodeling |
| Key signaling pathways | NOTCH signaling, APOE-NOTCH axis, phospholipase C epsilon signaling |
| Disease relevance | Congenital heart defects including tetralogy of Fallot and semilunar valvulogenesis defects |
What Is GO:0003193?
In our own words, GO:0003193 pulmonary valve formation refers to the early developmental steps that create the pulmonary valve from undifferentiated or unspecified precursor tissues. The process starts with the specific cellular and molecular events that lead to the appearance of a discrete valve structure and concludes when the structural rudiment can be recognized morphologically. It is a biological_process term, so it describes a coordinated sequence of developmental events rather than a single gene function or a cellular component. This term is distinct from later stages of valve remodeling, maturation, or disease-related calcification, which are covered by other ontology terms.
Why Is pulmonary valve formation Important in Cell Biology?
GO:0003193 pulmonary valve formation is important because it defines the earliest developmental window in which the pulmonary valve is established, and perturbations during this window can lead to congenital heart defects that require surgical or transcatheter intervention. Research on this process informs our understanding of semilunar valve biology, guides the interpretation of gene expression data from cardiac differentiation studies, and provides a foundation for developing regenerative or tissue-engineered valve strategies.
• Defects in pulmonary valve formation contribute to congenital heart disease, including tetralogy of Fallot and semilunar valvulogenesis defects.
• The process is a critical window for understanding how signaling pathways such as NOTCH and APOE-NOTCH govern elastogenesis during human cardiac valve remodeling.
• Mouse models deficient in phospholipase C epsilon show congenital semilunar valvulogenesis defects, directly linking molecular pathways to pulmonary valve formation.
• Surgical correction of tetralogy of Fallot with pulmonary valve formation from the right atrium highlights the clinical relevance of valve developmental biology.
• Transcatheter pulmonary valve replacement research, including new polycarbonate urethane valves, depends on understanding native valve formation and function.
• Pulmonary valve mechanics in the aortic position have been studied to inform valve design and biomechanics.
• Subclinical thrombus formation in bioprosthetic pulmonary valve conduits is a clinical concern that relates to valve structure and remodeling.
• Pulmonary valve replacement for pulmonary thrombus formation after previous aortic valve replacement illustrates the clinical complexity of valve disease.
• GO:0003193 provides a precise annotation target for transcriptomic and functional genomic studies of cardiac development.
• CRISPR-based models enable causal testing of candidate genes in pulmonary valve formation, accelerating translational research.
What Happens During pulmonary valve formation?
Initiation from unspecified parts
In simple terms: The pulmonary valve starts to form from cells that have not yet committed to a specific valve fate.
According to the QuickGO definition, pulmonary valve formation begins with the specific processes that contribute to the appearance of the discrete structure from unspecified parts. This initiation phase involves the recruitment and patterning of precursor cells in the right ventricular outflow tract. Experimental evidence from mouse models indicates that signaling molecules such as phospholipase C epsilon are required for normal semilunar valvulogenesis, and their deficiency leads to congenital semilunar valvulogenesis defects. This stage is therefore a critical window for gene regulatory networks that specify valve precursor identity.
Endocardial cushion formation and patterning
In simple terms: Cells in the developing heart cluster together to form cushions that will become the valve leaflets.
During pulmonary valve formation, endocardial cells undergo an epithelial-to-mesenchymal transition and contribute to the formation of endocardial cushions, which are the precursors of the valve leaflets. The NOTCH signaling pathway and APOE-NOTCH axis have been implicated in elastogenesis during human cardiac valve remodeling, a process that follows initial formation and is essential for valve structural integrity. The precise patterning of these cushions determines the future morphology of the pulmonary valve.
Recognition of the structural rudiment
In simple terms: The valve becomes visible as a distinct structure, marking the end of the initial formation process.
The QuickGO definition states that pulmonary valve formation ends when the structural rudiment is recognizable. At this point, the discrete valve structure has formed and can be identified morphologically. This endpoint distinguishes GO:0003193 from later remodeling and maturation processes. Studies of semilunar valvulogenesis in mice have helped define the morphological landmarks that correspond to this transition.
Coordination with outflow tract development
In simple terms: The pulmonary valve forms in coordination with the rest of the heart's outflow tract.
Pulmonary valve formation does not occur in isolation; it is coordinated with the development of the right ventricular outflow tract and the pulmonary artery. Clinical research on tetralogy of Fallot, a congenital heart defect that affects the pulmonary valve and outflow tract, has explored surgical strategies including pulmonary valve formation from the right atrium. This highlights the importance of understanding how valve formation integrates with broader cardiac morphogenesis.
Molecular regulation by signaling pathways
In simple terms: Specific molecular signals tell the valve cells when and where to form.
Multiple signaling pathways regulate pulmonary valve formation. Phospholipase C epsilon is required for normal semilunar valvulogenesis, as demonstrated by congenital defects in mice deficient in this enzyme. The APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling, providing a molecular link between lipid metabolism, NOTCH signaling, and valve extracellular matrix organization. These pathways represent potential targets for functional studies using CRISPR-based models.
Key Genes Involved in GO:0003193 pulmonary valve formation
The following genes and proteins have been implicated in pulmonary valve formation, semilunar valvulogenesis, or related cardiac valve developmental processes based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLCE1 | Phospholipase C epsilon; required for semilunar valvulogenesis | Mouse deficiency causes congenital semilunar valvulogenesis defects |
| APOE | Lipid transport; regulates elastogenesis via NOTCH axis | Governs elastogenesis during human cardiac valve remodeling |
| NOTCH1 | Cell fate signaling; elastogenesis regulation | APOE-NOTCH axis in valve remodeling |
| NOTCH2 | Cell fate signaling in valve development | Component of NOTCH signaling in cardiac valve remodeling |
| NOTCH3 | Vascular and valve cell signaling | Part of APOE-NOTCH axis in elastogenesis |
| NOTCH4 | Endothelial signaling | Potential role in valve endothelial-to-mesenchymal transition |
| ELN | Elastin; extracellular matrix component | Elastogenesis target of APOE-NOTCH axis in valve remodeling |
| GATA4 | Cardiac transcription factor | Candidate regulator of outflow tract and valve development |
| NKX2-5 | Cardiac transcription factor | Essential for cardiac development including outflow tract |
| TBX1 | Transcription factor in pharyngeal apparatus | Associated with conotruncal heart defects |
| TBX20 | Cardiac transcription factor | Regulates valve and chamber development |
| BMP2 | Signaling ligand in endocardial cushion formation | Promotes epithelial-to-mesenchymal transition in valves |
| BMP4 | Signaling ligand in outflow tract development | Required for endocardial cushion formation |
| TGFB1 | Signaling ligand in valve remodeling | Regulates extracellular matrix production |
| VEGFA | Angiogenic signaling | Influences valve endothelial cell behavior |
| SOX9 | Chondrogenic transcription factor | Expressed in developing valve mesenchyme |
| COL1A1 | Collagen type I; extracellular matrix | Structural component of valve leaflets |
| COL3A1 | Collagen type III; extracellular matrix | Contributes to valve mechanical properties |
How Is pulmonary valve formation Regulated?
Pulmonary valve formation is regulated by a combination of transcriptional networks and intercellular signaling pathways. The APOE-NOTCH axis has been shown to govern elastogenesis during human cardiac valve remodeling, linking lipid metabolism to NOTCH-dependent gene expression and extracellular matrix organization. Phospholipase C epsilon signaling is required for normal semilunar valvulogenesis, as its deficiency in mice leads to congenital semilunar valvulogenesis defects. These pathways operate within the broader context of cardiac outflow tract development, where transcription factors such as GATA4, NKX2-5, and TBX1 coordinate gene expression. The precise temporal and spatial regulation of these signals ensures that the pulmonary valve forms at the correct location and time during embryogenesis.
pulmonary valve formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLCE1 | Congenital semilunar valvulogenesis defects | Knockout mouse; CRISPR KO in cardiac differentiation |
| APOE | Valve remodeling and elastogenesis disorders | Knockout or knock-in models; APOE-NOTCH axis studies |
| NOTCH1 | Congenital heart defects; valve remodeling | Conditional knockout; point mutation models |
| GATA4 | Congenital heart defects; outflow tract anomalies | Knock-in of patient variants; overexpression |
| TBX1 | Conotruncal heart defects; tetralogy of Fallot | Knockout and knock-in models; CRISPR screening |
Congenital heart defects and tetralogy of Fallot
Disruption of pulmonary valve formation is associated with congenital heart defects, most notably tetralogy of Fallot, which involves obstruction of the right ventricular outflow tract and abnormalities of the pulmonary valve. Surgical correction strategies have explored pulmonary valve formation from the right atrium, demonstrating the clinical importance of understanding normal valve development. These defects arise from perturbations during the initial formation window described by GO:0003193.
Semilunar valvulogenesis defects
Mice deficient in phospholipase C epsilon exhibit congenital semilunar valvulogenesis defects, providing direct experimental evidence that specific molecular pathways are required for pulmonary valve formation. This model has been instrumental in defining the genetic requirements for normal semilunar valve development and in identifying candidate genes for human congenital valve disease.
Valve remodeling and elastogenesis disorders
The APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling, and its dysregulation may contribute to valve structural abnormalities. While remodeling occurs after initial formation, the molecular machinery involved is closely related to developmental programs, and defects in elastogenesis can lead to valve dysfunction later in life.
Bioprosthetic valve complications and thrombosis
Subclinical thrombus formation in bioprosthetic pulmonary valve conduits is a recognized clinical concern, and research has examined the mechanisms and implications of this process. Additionally, pulmonary valve replacement for pulmonary thrombus formation after previous aortic valve replacement illustrates the complex clinical scenarios involving the pulmonary valve. These complications underscore the importance of understanding native valve biology and formation.
From pulmonary valve formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PLCE1 required for pulmonary valve formation? | PLCE1 knockout mouse or CRISPR KO in cardiac organoids |
| Does APOE-NOTCH signaling regulate elastogenesis in valve remodeling? | APOE knockout or NOTCH reporter knock-in models |
| What is the effect of a patient variant in GATA4 on valve development? | Point mutation knock-in in iPSC-derived cardiac cells |
| Can overexpression of NOTCH1 rescue valve formation defects? | Overexpression models in zebrafish or mouse |
| Which genes are essential for semilunar valvulogenesis? | CRISPR library screening in cardiac differentiation systems |
| How does TBX1 dosage affect pulmonary valve formation? | Knock-in of hypomorphic alleles or overexpression models |
How to Study the pulmonary valve formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes during valve formation | Identify transcriptional programs in wild-type vs mutant models |
| CRISPR library screening | Essential genes for valve formation | Systematic knockout in cardiac differentiation cultures |
| Confocal microscopy | Morphology of developing valve structures | Visualize pulmonary valve rudiment formation |
| Proteomics | Protein composition of developing valves | Quantify elastin and collagen deposition |
| Single-cell RNA-seq | Cell type-specific expression in outflow tract | Define cell populations contributing to valve formation |
| ATAC-seq | Chromatin accessibility in valve precursor cells | Identify regulatory elements driving valve gene expression |
| In situ hybridization | Spatial expression of candidate genes | Localize transcripts in developing pulmonary valve |
Transcriptomic profiling of valve development
RNA sequencing of developing outflow tract tissues or cardiac differentiation cultures can identify genes whose expression changes during pulmonary valve formation. Comparing wild-type and mutant models, such as PLCE1-deficient mice, reveals pathways required for semilunar valvulogenesis. These datasets can be annotated with GO:0003193 to focus on the initial formation window.
Functional genomic screening with CRISPR libraries
CRISPR library screening enables systematic knockout of candidate genes in cardiac differentiation systems to identify regulators of pulmonary valve formation. This approach can uncover novel genes beyond those already implicated, such as PLCE1 and APOE-NOTCH components. Hits can be validated in animal models and human iPSC-derived valve cells.
Imaging and morphological analysis
High-resolution imaging of developing hearts, including optical coherence tomography and confocal microscopy, allows visualization of the pulmonary valve rudiment as it forms. These methods define the endpoint of GO:0003193, when the structural rudiment becomes recognizable. Mouse models with semilunar valvulogenesis defects provide contrast for identifying abnormal morphology.
Proteomic and extracellular matrix analysis
Proteomic profiling of developing valves can quantify extracellular matrix components such as elastin and collagens, which are regulated by the APOE-NOTCH axis during valve remodeling. Mass spectrometry-based approaches can identify post-translational modifications and protein interactions that contribute to valve formation.
How CRISPR Can Be Used to Study GO:0003193 pulmonary valve formation
Knockout
CRISPR knockout of candidate genes such as PLCE1 or NOTCH family members in cardiac differentiation systems or animal models can test their requirement for pulmonary valve formation. Mouse knockouts of phospholipase C epsilon have already demonstrated congenital semilunar valvulogenesis defects, validating this approach. Knockout studies help distinguish genes that are essential for initial formation from those involved in later remodeling.
Point Mutation
Point mutation knock-in using CRISPR can model patient-specific variants in genes such as GATA4 or TBX1, which are associated with congenital heart defects. These models allow researchers to determine whether a specific variant disrupts pulmonary valve formation and to study the underlying molecular mechanisms. Point mutations in NOTCH pathway genes can also be introduced to dissect signaling requirements.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins or epitope tags, into endogenous loci enables visualization and tracking of cells during pulmonary valve formation. Tagged knock-in of NOTCH receptors or APOE can facilitate biochemical studies of the APOE-NOTCH axis in valve remodeling. These models are valuable for lineage tracing and protein interaction studies.
Overexpression
CRISPR-mediated overexpression or transgenic overexpression of candidate genes can test whether increased dosage of a factor such as NOTCH1 or APOE promotes or disrupts pulmonary valve formation. Overexpression models complement knockout studies by revealing gain-of-function effects and can identify dosage-sensitive pathways. These approaches are particularly useful for studying signaling molecules that act in a concentration-dependent manner.
How EDITGENE Supports pulmonary valve formation Research
Researchers studying pulmonary valve formation-related genes often need to determine whether a candidate gene is causally involved in the developmental process, and CRISPR-based models provide a direct way to test this. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to dissect the molecular requirements for GO:0003193 in physiologically relevant systems.
Contact EDITGENE today to design your custom CRISPR model for pulmonary valve formation research.
Frequently Asked Questions About pulmonary valve formation
What is GO:0003193 pulmonary valve formation?
GO:0003193 is a Gene Ontology biological_process term that describes the developmental process pertaining to the initial formation of the pulmonary valve from unspecified parts, ending when the structural rudiment is recognizable.
What genes are involved in pulmonary valve formation?
Genes implicated in pulmonary valve formation and related semilunar valvulogenesis include PLCE1, APOE, NOTCH family members, GATA4, NKX2-5, TBX1, and extracellular matrix genes such as ELN and collagens.
Why is pulmonary valve formation important for congenital heart disease?
Disruption of pulmonary valve formation contributes to congenital heart defects such as tetralogy of Fallot and semilunar valvulogenesis defects, which require surgical or transcatheter intervention.
What signaling pathways regulate pulmonary valve formation?
The APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling, and phospholipase C epsilon signaling is required for normal semilunar valvulogenesis.
How can CRISPR be used to study pulmonary valve formation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of candidate genes in pulmonary valve formation and to dissect molecular mechanisms.
What animal models are used to study pulmonary valve formation?
Mouse models, particularly those deficient in phospholipase C epsilon, have been used to study congenital semilunar valvulogenesis defects. Surgical models of tetralogy of Fallot correction also inform clinical translation.
What is the difference between pulmonary valve formation and remodeling?
Pulmonary valve formation (GO:0003193) covers the initial development of the valve rudiment, while remodeling involves later changes in extracellular matrix composition and elastogenesis, such as those governed by the APOE-NOTCH axis.
What research methods are used to study pulmonary valve formation?
Common methods include RNA-seq, single-cell RNA-seq, CRISPR library screening, confocal imaging, proteomics, and in situ hybridization to characterize gene expression and morphology during valve development.
What diseases are associated with defects in pulmonary valve formation?
Diseases include tetralogy of Fallot, congenital semilunar valvulogenesis defects, and other conotruncal heart anomalies. Clinical complications such as bioprosthetic valve thrombosis also relate to pulmonary valve biology.
How does EDITGENE support pulmonary valve formation research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services to support functional studies of genes involved in pulmonary valve formation.
Conclusion
GO:0003193 pulmonary valve formation is a precisely defined biological_process term that captures the initial developmental steps leading to the recognizable pulmonary valve rudiment. Research on this process has identified key molecular players, including phospholipase C epsilon and the APOE-NOTCH axis, and has linked defects to congenital heart disease such as tetralogy of Fallot. Understanding the mechanisms of pulmonary valve formation provides a foundation for translational advances in valve repair, replacement, and tissue engineering. CRISPR-based functional genomics offers a powerful approach to systematically dissect the genetic requirements for this process and to accelerate the discovery of new therapeutic targets.
References
- 1. Jewgenow P et al.. 2019. Subclinical thrombus formation in bioprosthetic pulmonary valve conduits.. Int J Cardiol 281:113-118 PMID: 30732866
- 2. Sigler M et al.. 2019. Subclinical thrombus formation in bioprosthetic pulmonary valve conduits: Reply to Wei.. Int J Cardiol 293:223 PMID: 31447036
- 3. Avşar MK et al.. 2025. Early results of complete surgical correction of tetralogy of Fallot with pulmonary valve formation from the right atrium: a comparative analysis with traditional correction without valve construction.. Cardiol Young 35(9):1824-1843 PMID: 40908924
- 4. Eigel P et al.. 2005. Pulmonary valve replacement for pulmonary thrombus formation after previous aortic valve replacement, Guillain-Barré syndrome and enterococcal sepsis.. Interact Cardiovasc Thorac Surg 4(6):521-2 PMID: 17670473
- 5. Lutter G et al.. 2021. Transcatheter pulmonary valve replacement: a new polycarbonate urethane valve.. Eur J Cardiothorac Surg 59(5):1048-1056 PMID: 33538794
- 6. Liu Z et al.. 2024. APOE-NOTCH axis governs elastogenesis during human cardiac valve remodeling.. Nat Cardiovasc Res 3(8):933-950 PMID: 39196035
- 7. Soares AL et al.. 2014. Mechanics of the pulmonary valve in the aortic position.. J Mech Behav Biomed Mater 29:557-67 PMID: 24035437
- 8. Tadano M et al.. 2005. Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon.. Mol Cell Biol 25(6):2191-9 PMID: 15743817
